Richard A. Heyman - 10 Sep 2021 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
10 Sep 2021
Net transactions value
-$27,056
Form type
4
Filing time
14 Sep 2021, 16:03:31 UTC
Previous filing
09 Sep 2021
Next filing
16 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale $12,023 -479 -0.22% $25.10 218,261 10 Sep 2021 See footnote F1, F2, F3
transaction ORIC Common Stock Sale $15,033 -601 -0.28% $25.01 217,660 13 Sep 2021 See footnote F1, F3, F4
holding ORIC Common Stock 12,500 10 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by RAHD Capital, LLC.
F2 Represents the weighted average share price of an aggregate total of 479 shares sold in the price range of $25.05 to $25.17 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.
F4 Represents the weighted average share price of an aggregate total of 601 shares sold in the price range of $25.00 to $25.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.